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In recent years, the highly conserved Lin28 RNA-binding proteins have emerged as factors that define stem-
ness in several tissue lineages. Lin28 proteins repress let-7 microRNAs and influence mRNA translation,
thereby regulating the self-renewal of mammalian embryonic stem cells. Subsequent discoveries revealed
that Lin28a and Lin28b are also important in organismal growth and metabolism, tissue development,
somatic reprogramming, and cancer. In this review, we discuss the Lin28 pathway and its regulation, outline
its roles in stem cells, tissue development, and pathogenesis, and examine the ramifications for re-engineer-
ing mammalian physiology.A central question in stem cell biology is whether common fac-
tors exist to define ‘‘stemness’’ in multiple tissue lineages. Argu-
ably, one such candidate is theRNA-binding protein Lin28,which
was first identified in the nematode C. elegans through screens
for lineage-modifying genes that alter developmental timing or
heterochrony (lin-28) (Ambros and Horvitz, 1984). Two other
prominent heterochronic genes, lin-4 and let-7, were the first
microRNAs (miRNAs) to be discovered, and both miRNAs
directly repress lin-28 to suppress heterochronic reiterations
of cell lineages. Heterochronic ‘‘reiteration’’ of nematode stem
cells, as C. elegans geneticists first demonstrated, was strongly
reminiscent of mammalian stem cell self-renewal (Chalfie et al.,
1981; Ambros and Horvitz, 1984). This connection was rein-
forced by the discovery that mouse embryonic stem cells
(ESCs) express high levels of mammalian Lin28, which decrease
upon differentiation (Moss and Tang, 2003). Successful reprog-
ramming of human fibroblasts into induced pluripotent stemcells
(iPSCs) with the use of Lin28, along with Oct4, Sox2, and Nanog,
further corroborated its role in pluripotent stem cells (Yu et al.,
2007a), but the mechanism of action for Lin28 remained unclear.
A subsequent flurry of studies showing that Lin28 directly inhibits
let-7maturation in ESCs rapidly validated Lin28’s function in ESC
self-renewal (Viswanathan et al., 2008; Rybak et al., 2008; Heo
et al., 2008; Newman et al., 2008). With the discovery that
Lin28 is also important in cancer, the germ lineage, and cellular
metabolism (Viswanathan et al., 2009; West et al., 2009; Zhu
et al., 2011), understanding the role of Lin28 in stem cells during
development and disease pathogenesis has emerged as a new
field of research. In this review,wewill discuss the Lin28 pathway
and its complexmolecularmechanisms, outline its known roles in
stem cells, tissue development, and pathogenesis, and examine
its ramifications for re-engineering mammalian physiology.
Lin28/let-7: A Conserved Bistable Switch
Current insights into Lin28 rest heavily on precedents in
C. elegans genetics. Lin-28 was first discovered through muta-genesis screens for heterochronic genes (Horvitz and Sulston,
1980; Sulston and Horvitz, 1981; Ambros and Horvitz, 1984).
Loss of function in lin-28 accelerates differentiation of the hypo-
dermal and vulval stem cells (called seam cells and VPCs,
respectively, in nematodes). In contrast, gain of function in lin-
28 promotes self-renewal and delays differentiation of the hypo-
dermal and vulval stem cells, leading to the proliferation of hypo-
dermal stemcells and acell-cycle delay in vulval stemcells (Moss
et al., 1997). Lin-28 is highly expressed during embryogenesis
and early larval development in the hypodermal, neural, andmus-
cle cells but gradually diminishes and disappears by adulthood.
Two heterochronic miRNAs (lin-4 and let-7) repress lin-28
posttranscriptionally via direct binding sites in its 30 untranslated
region (30 UTR) (Reinhart et al., 2000; Pasquinelli et al., 2000;
Roush and Slack, 2008). Although canonical let-7 is only ex-
pressed late in larval development to drive the transition to adult-
hood, three let-7 homologs (mir-48,mir-84, andmir-241) display
overlapping expression with lin-28. Indeed, loss of function in
these let-7 homologs phenocopied lin-28 gain of function in
the hypodermal stem cells and lin-28 was epistatic to the three
let-7 homologs (Abbott et al., 2005). Mutation of the let-7 binding
site in the lin-28 30 UTR also led to an increase in lin-28 30 UTR-
lacZ reporter expression (Morita and Han, 2006), suggesting that
let-7 binding contributes to lin-28 repression and underlies their
opposing roles in regulating differentiation.
The role of lin-28 in mammalian stem cells was less clear until
quite recently. The first glimpse of a connection came from the
discovery that the mammalian lin-28 ortholog is highly ex-
pressed in mouse ESCs and human embryonal carcinoma cells
(Moss and Tang, 2003). The connection was further validated
when human Lin28 was used along with Oct4, Sox2, and Nanog
to reprogram human somatic fibroblasts into pluripotent stem
cells (Yu et al., 2007a). Around the same time, a posttranscrip-
tional mechanism was proposed to be responsible for the dra-
matic disparity between high levels of pri-let-7 transcript and
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Figure 1. Overview of Molecular
Mechanisms Underlying Lin28 Function
Both Lin28a and Lin28b have been observed to
shuttle between the nucleus and cytoplasm,
binding pri- and pre-let-7. In the nucleus, Lin28a
and Lin28b could potentially work in tandem with
the heterogeneous nuclear ribonucleoproteins
(hnRNPs) to regulate splicing or with Musashi-1
(Msi1) to block pri-let-7 processing. In the cyto-
plasm, Lin28a recruits Tut4 and Tut7 to oligo-
uridylate pre-let-7 and block Dicer processing in to
mature let-7 miRNA (right, violet). Lin28a also
recruits RNA helicase A (RHA) to regulate mRNA
processing in messenger ribonucleoprotein
(mRNP) complexes, in tandem with the Igf2bps,
poly(A)-binding protein (PABP), and the eukaryotic
translation initiation factors (eIFs). In response to
unknown signals and stimuli, themRNAs are either
shuttled into polyribosomes for translation, stress
granules for temporary sequestering, or P-bodies
for degradation, in part via miRNAs and the Ago2
endonuclease (left, orange).
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two lines of inquiry rapidly converged through a flurry of studies
that showed that Lin28 (now routinely termed Lin28a) and its
paralog Lin28b directly inhibit the posttranscriptional maturation
of let-7 in ESCs (Viswanathan et al., 2008; Rybak et al., 2008;
Heo et al., 2008; Newman et al., 2008). A generally similar mech-
anism was later verified to be conserved in C. elegans (Lehrbach
et al., 2009; VanWynsberghe et al., 2011). Given that Lin28a and
Lin28b inhibit the biogenesis of let-7 miRNAs, which, in turn,
repress Lin28a and Lin28b expression, it became clear that
this bistable switch represents a central mechanism that governs
stem cell self-renewal from worms to mammals.
Molecular Mechanisms of Lin28 Function
Following the discovery that Lin28a and Lin28b repress let-7
biogenesis, several groups set about to determine the detailed
biochemical mechanisms underlying let-7 repression as a model
for understanding miRNA biogenesis. Similar to the biogenesis
of other miRNAs, let-7 is first transcribed as part of long pri-
let-7 transcripts in the nucleus (Roush and Slack, 2008). Within
the pri-let-7 transcripts, there is a hairpin structure that is the pre-
cursor miRNA (pre-let-7). Drosha, in complex with its RNA-bind-
ing cofactor DGCR8, cleaves and releases the 70 nt hairpin
structure to produce pre-let-7. Like other pre-miRNAs, pre-
let-7 is then thought to be exported from the nucleus into the
cytoplasm by exportin-5, although the majority of pre-let-7 spe-
cies lack the 30 2 nt overhang that exportin-5 presumably needs
to export pre-miRNAs (Heo et al., 2012; Yi et al., 2003), suggest-
ing that another mechanism might serve this function. In the
cytoplasm, pre-let-7 is further processed by Dicer to produce
a 22 nt double-stranded RNA duplex. Mature single-stranded
let-7 is then incorporated from the duplex into the RNA-induced
silencing complex to target mRNAs for translation inhibition and/
or degradation in processing bodies (P-bodies) (Figure 1).396 Cell Stem Cell 12, April 4, 2013 ª2013 Elsevier Inc.In a multipronged fashion, Lin28a
and Lin28b bind to both pri-let-7 and
pre-let-7, effectively sabotaging the post-
transcriptional processing of let-7 (Viswa-
nathan et al., 2008; Rybak et al., 2008;Heo et al., 2008; Newman et al., 2008). X-ray crystallography
studies further revealed that Lin28a binds pre-let-7 at the termi-
nal loop and at the bulge GGAGmotif where Dicer cleaves (Nam
et al., 2011). Lin28a also recruits Tut4 (Zcchc11), a cytoplasmic
terminal uridylyl transferase, to oligo-uridylate pre-let-7 and pre-
vents its processing by Dicer (Heo et al., 2009; Hagan et al.,
2009). Recent studies have further elaborated on this mecha-
nism, suggesting that Tut7 (Zcchc6) is a redundant homolog of
Tut4 that can also oligo-uridylate pre-let-7 in the presence of
Lin28a (Thornton et al., 2012; Heo et al., 2012). In contrast,
when Lin28a is absent, Tut4, Tut7, or Tut2 (Papd4/Gld2) mono-
uridylates pre-let-7s at their 30 1 nt overhang to generate a 2 nt
overhang, thereby enabling their processing by Dicer (Heo
et al., 2012). Thus, one would expect oligo-uridylated pre-let-7
to accumulate when pri-let-7, Lin28a, and Tut4 and Tut7 are pre-
sent. But this was not observed, suggesting that an unknown
nuclease must exist to degrade oligo-uridylated pre-let-7s
(Heo et al., 2008, 2009) and/or that Lin28 can sequester pri-
let-7s to prevent further processing (Viswanathan et al., 2008;
Newman et al., 2008). Indeed, a study suggests that Lin28b is
predominantly localized in the nucleolus where it can sequester
pri-let-7 away from Drosha and DGCR8 processing, whereas
Lin28a is predominantly localized in the cytoplasm, where it
can recruit Tut4 to oligo-uridylate pre-let-7 and prevent Dicer
processing (Piskounova et al., 2011). However, mammalian
Lin28a and Lin28b andC. elegans lin-28 can all enter the nucleus
as well as the cytoplasm (Moss et al., 1997; Guo et al., 2006;
Balzer and Moss, 2007; Heo et al., 2008; Piskounova et al.,
2011; Van Wynsberghe et al., 2011; Vogt et al., 2012; Hafner
et al., 2013). Moreover, all three proteins possess a putative
nucleolar localization signal, and all three proteins can bind
to both pri- and pre-let-7 (Viswanathan et al., 2008; Rybak
et al., 2008; Heo et al., 2008; Newman et al., 2008; Lehrbach
et al., 2009; Van Wynsberghe et al., 2011). Thus, the mode of
Figure 2. Signals Upstream and Targets Downstream of Lin28 in the
Lin28 Pathway
The lin-4 homolog miR-125a/miR-125b represses both Lin28a and Lin28b
during stem cell differentiation. The core pluripotency transcription factors
Oct4, Sox2, Nanog, and Tcf3 can activate Lin28a transcription in ESCs and
iPSCs, whereas the growth regulator Myc and the inflammation- and stress-
responsive NF-kB can transactivate Lin28b. A putative steroid hormone-
activated nuclear receptor, conserved from C. elegans daf-12, might also
regulate Lin28a and Lin28b and let-7 expression. Downstream of Lin28a and
Lin28b, the let-7 family represses a network of proto-oncogenes, including the
insulin-PI3K-mTOR pathway, Ras, Myc, Hmga2, and the Igf2bps. At the same
time, Lin28a can also directly bind to and regulate translation of mRNAs,
including Igf2bps, Igf2, Hmga1, and mRNAs encoding metabolic enzymes,
ribosomal peptides, and cell-cycle regulators. Altogether, this broad network
of targets allows Lin28 to program both metabolism and growth to regulate
self-renewal.
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remains unclear (Figure 1).
Under different conditions of metabolic stress in embryonal
carcinoma cells and myoblasts, Lin28a localizes specifically to
cytoplasmic stress granules where mRNAs are sequestered
and mRNA translation is temporarily stalled (Balzer and Moss,
2007; Polesskaya et al., 2007). Under normal growth conditions,
cytoplasmic Lin28a can directly or indirectly associate with
translation initiation factors eIF3B and eIF4E, elongation factors
EF1a and EF1a2, ribosomal proteins, poly(A)-binding protein,
Igf2bps, Musashi1 (Msi1), and RNA helicase A (RHA) in
messenger ribonucleoprotein complexes to regulate mRNA
translation (Balzer and Moss, 2007; Polesskaya et al., 2007; Jin
et al., 2011). When point mutations are introduced into the
RNA-binding motifs, Lin28a localizes to the nucleus (Balzer and
Moss, 2007). These findings suggest a model in which Lin28a
regulates the posttranscriptional processing of itsmRNA targets,
perhaps by first binding them in the nucleus and subsequently
shuttling them between ribosomes, P-bodies, or stress granules
for translational regulation, depending on the environmental con-
ditions. It would be interesting to know which factors sense the
environmental conditions for the regulation of this shuttling of
Lin28a and whether these conditions alter the RNAs bound by
Lin28a (Figure 1). One study, for example, suggests that retinoic
acid-induced differentiation of ESCs triggers Msi1 expression,
which recruits Lin28a to the nucleus to sequester and inhibit
pri-miR-98 but not pri-let-7b (Kawahara et al., 2011). But what
else could Lin28a and Lin28b be doing in the nucleus? Nuclear
Lin28 could also regulate the alternative splicing of pre-mRNAs,
or processing of small nucleolar RNAs (snoRNAs) and long
noncoding RNAs to generate greater RNA diversity. The likeli-
hood for this additional role is supported by the RNA-dependent
association between Lin28a protein and nuclear splicing factors,
such as heterogeneous ribonucleoproteins F andH1 (Polesskaya
et al., 2007), and its direct regulation of splicing factors and
snoRNAs (Wilbert et al., 2012; Hafner et al., 2013). How these
various RNA-processing mechanisms relate to stem cell self-
renewal and plasticity in response to environmental changes re-
mains an important avenue for future research.
Regulatory Signals Upstream of Lin28
Throughout their lifespans, stem cells must decide whether to
self-renew, proliferate, differentiate or die. The regulation of
stem cell homeostasis is a complex process that involves inte-
grating intrinsic and extrinsic signals so that stem cells can
correctly adapt to the environment. The central role of the
Lin28/let-7 bistable switch in governing stem cell self-renewal
raises a provocative question: what signaling pathways con-
verge upstream to regulate the switch?
In C. elegans, an important intrinsic signal upstream of lin-28
that regulates hypodermal stem cell self-renewal is the miRNA
lin-4. In vertebrates, lin-4 is conserved as miR-125a and miR-
125b (Lagos-Quintana et al., 2002). Vertebrate miR-125/lin-4
has been shown to be critical for regulating processes as dispa-
rate as neurogenesis, somitogenesis, hematopoiesis, myogene-
sis, and epidermal stem cell self-renewal (Rybak et al., 2008; Le
et al., 2009a; Le et al., 2009b; Klusmann et al., 2010; Bousquet
et al., 2010; O’Connell et al., 2010; Ooi et al., 2010; Ge et al.,
2011; Zhang et al., 2011a; Guo et al., 2010; Chaudhuri et al.,2012). During these developmental processes, miR-125/lin-4
appears to regulate stem cell self-renewal and progenitor differ-
entiation by repressing a variety of different targets, including
Lin28a and Lin28b , as well as the p53 network (Le et al.,
2011). In mammalian ESCs, the pluripotency factors Oct4,
Sox2, Nanog, and Tcf3 have also been shown to regulate the
transcription of Lin28a (Marson et al., 2008). Among these
pluripotency factors, Sox2 appears to be the most critical for
regulating Lin28a expression, on the basis of Bayesian probabi-
listic network modeling of single-cell gene expression data
during iPSC reprogramming (Buganim et al., 2012). Interestingly,
Sox2 directly binds to Lin28a in a nuclear protein-protein com-
plex, suggesting a close relationship between Sox2 and Lin28a
in pluripotency (Cox et al., 2010). Repression of the Dot1L
H3K79 histone methyltransferase upregulates Lin28a during re-
programming, although themechanism is indirect and occurs via
mesenchymal regulators downstream of TGFb signaling (Onder
et al., 2012). Finally, c-Myc and NF-kB transactivate Lin28b in
transformed cancer cells (Chang et al., 2009; Iliopoulos et al.,
2009), suggesting that Lin28a and Lin28b possess distinct cis-
regulatory elements to drive their transcription (Figure 2). BeyondCell Stem Cell 12, April 4, 2013 ª2013 Elsevier Inc. 397
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tion factors that regulate Lin28a and Lin28b expression
during mammalian development, and additional investigation is
warranted.
The C. elegans nuclear receptor daf-12 feeds extrinsic signals
from steroid hormones to lin-28 and let-7 to regulate diapause
or dauer arrest (Antebi et al., 1998, 2000; Gerisch et al., 2007;
Bethke et al., 2009; Hammell et al., 2009). Although this mech-
anism is well-characterized in C. elegans development and a
similar ecdysone-let-7mechanism operates in Drosophilameta-
morphosis (Sokol et al., 2008; Chawla and Sokol, 2012), it is
unclear if a similar mechanism exists to hormonally regulate
the Lin28/let-7 switch in mammals (Figure 2). Studies have
shown that the homologous retinoic acid receptors and estro-
gen receptor a regulate let-7 expression in vitro (Thomson
et al., 2006; Wulczyn et al., 2007; Gehrke et al., 2010; Schulz
et al., 2011; Bhat-Nakshatri et al., 2009), but both the directness
and the physiological relevance of these mechanisms remain to
be shown. It would also be interesting to test if any of the
nuclear hormone receptors implicated in pluripotency and
especially the naive state (Feng et al., 2009; Heng et al., 2010;
Guo and Smith, 2010; Wang et al., 2011; Martello et al.,
2012), a state associated with rodent diapause (Nichols et al.,
2001; Nichols and Smith, 2009), also regulate the Lin28/let-7
switch (Figure 2).
Coordinate Regulation of Metabolism and Cell Cycle by
Downstream Targets of Lin28
Given our wealth of understanding of the upstream regulators of
lin-28 in worms, it is surprising that relatively little was discerned
about the downstream RNA targets in the C. elegans literature. It
was only after the discovery that lin-28 directly binds to and re-
presses pre-let-7 that the more well-known let-7 targets could
be placed downstream of lin-28.Only some of these let-7 targets
are known to be conserved in mammals, including lin-41
(Trim71), let-60 (Ras), and Lin28 itself. The regulation of NRAS
and KRAS by let-7 in human cancer cells has led to the pro-
posal that let-7 functions as a tumor suppressor in humans
(Johnson et al., 2005). Indeed, a network of let-7 targets involv-
ing numerous other proto-oncogenes has been uncovered
in mammalian cells, including Myc, Hmga2, Igf2bps, cyclins
(Sampson et al., 2007; Mayr et al., 2007; Lee and Dutta, 2007;
Johnson et al., 2007; Yu et al., 2007b; Boyerinas et al., 2008; Ilio-
poulos et al., 2009; Legesse-Miller et al., 2009; Chang et al.,
2012), and components of the insulin-PI3K-mTOR pathway,
such as Igf1r, Insr, Irs2, Akt2, and Rictor (Zhu et al., 2011; Frost
and Olson, 2011). These studies fit with the suggestion that
Lin28a and Lin28b function as oncogenes in multiple cancers
by repressing the let-7 network (Viswanathan et al., 2009). How-
ever, a majority of these studies were conducted in vitro, and
many of these claims still await validation in vivo through
Lin28a and Lin28b or let-7 mouse models.
Adding a second layer of complexity downstream of Lin28,
some studies have shown that Lin28a directly binds to many
mRNAs, including Igf2 in myoblasts and neural progenitors,
and cyclin A and cyclin B in ESCs, to directly enhance their
translation independently of let-7 (Polesskaya et al., 2007; Xu
et al., 2009; Balzer et al., 2010). Genome-wide RNA immunopre-
cipitation studies revealed thousands of mRNA targets bound398 Cell Stem Cell 12, April 4, 2013 ª2013 Elsevier Inc.directly by Lin28. In human ESCs and cancer cells, LIN28A
directly binds and promotes the mRNA translation of numerous
metabolic enzymes, ribosomal peptides, and cyclins as well as
splicing factors (Peng et al., 2011; Li et al., 2012; Wilbert et al.,
2012; Hafner et al., 2013). Curiously, in mouse ESCs, Lin28a
was also recently found to bind and subtly repress the ribosomal
occupancy of numerous membrane protein mRNAs (Cho et al.,
2012). Given the plethora of mRNA targets that are emerging
for Lin28a, including nearly 50% of the human transcriptome in
one study (Cho et al., 2012), an important task lying ahead is to
determine whether all these targets or only a subset contribute
to the Lin28 phenotypes observed in vivo. Such an undertaking
might require a return to the powerful genetics of C. elegans to
search for conserved mRNA targets of lin-28. This idea is sup-
ported by the finding that let-7-independent mechanisms must
account for the lin-28 phenotype in C. elegans as well (Vadla
et al., 2012).
Several key insights into Lin28 function are emerging from
the small set of well-validated targets, most notably the insight
that Lin28 coordinates both proliferative growth andmetabolism.
Lin28a and Lin28b can upregulate a large number of cell-cycle
regulators through let-7 repression, including Myc, Ras, cyclin
D1, cyclin D2, Cdk6, Cdc25a, Cdc34, Trim71 (which represses
p21Cip1), Hmga2 (which represses p16Ink4a and p19Arf), and
PI3K-Akt signaling (Johnson et al., 2005; Sampson et al., 2007;
Johnson et al., 2007; Chang et al., 2012; Mayr et al., 2007; Nish-
ino et al., 2008; Zhu et al., 2011). A recent study even suggested
that let-7 can directly bind to and silence Rb1 and E2F target
genes via heterochromatin during senescence (Benhamed
et al., 2012). Lin28a also directly binds and promotes the trans-
lation of mRNAs encoding cyclin A, cyclin B, cyclin D, Cdk1,
Cdk2, Cdk4, Cdc2, and Cdc20, thereby coordinating the cell
cycle at multiple checkpoints (Xu et al., 2009; Li et al., 2012; Haf-
ner et al., 2013). Besides the cell cycle, Lin28a and Lin28b might
also control cellular growth by regulating ribosomal synthesis of
proteins. Lin28a directly binds to the mRNAs of numerous ribo-
somal peptides in human ESCs (Peng et al., 2011). In addition,
Lin28a and Lin28b increase mTOR signaling via let-7 (Zhu
et al., 2011; Frost and Olson, 2011), which can activate ribo-
somal biogenesis and translation in many contexts. In parallel
with its extensive control of cell-cycle and cell-growth regulators,
Lin28a and Lin28b appear to also coordinate cellular meta-
bolism, both via let-7 and by directly stimulating mRNA
translation. Through let-7, Lin28a and Lin28b upregulate the in-
sulin-PI3K, Ras, and Myc pathways – all of which are oncogenic
regulators of metabolism (Vander Heiden et al., 2009; Dang,
2011). By directly binding mRNAs and influencing the translation
of Igf2bps, Igf2, glycolysis enzymes, and mitochondrial en-
zymes, Lin28a can directly potentiate cellular metabolism (Zhu
et al., 2011; Peng et al., 2011; Polesskaya et al., 2007; Janiszew-
ska et al., 2012; Hafner et al., 2013). Hmga1, another mRNA
target of Lin28a, can also upregulate insulin-PI3K signaling
(Liau et al., 2006; Chiefari et al., 2011; Peng et al., 2011). Given
how growth signaling pathways are intertwined with cellular
metabolism, it is perhaps not surprising that Lin28 would have
to program both arms of genes to regulate self-renewal. Thus,
a model, albeit an inchoate one, is emerging whereby Lin28 pro-
grams bothmetabolism and proliferative growth to regulate stem
and progenitor cell self-renewal (Figure 2).
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The functional role of Lin28 in cellular metabolism is evidenced
by recent studies in ESCs. Recent work has shown that aerobic
glycolysis, akin to theWarburg effect in cancer, is critical to ESCs
and iPSCs (Folmes et al., 2011). This is perhaps not surprising,
given the high proliferative capacity of ESCs and the importance
of glycolysis in providing carbon intermediates for anabolic
growth (Vander Heiden et al., 2009). What is surprising is that
some studies have shown that mitochondrial oxidative meta-
bolism is also critical to ESCs (Wang et al., 2009; Alexander
et al., 2011; Zhang et al., 2011b) despite the immature mor-
phology of ESC mitochondria. Interestingly, Lin28a binds to a
large number of mRNAs encoding mitochondrial enzymes in
human ESCs (Peng et al., 2011). One possibility is that ESCmito-
chondrial oxidation could be operating to recycle mitochondrial
NAD+ and keep the Krebs cycle running in order to generate fatty
acids and various amino acids for ESCs (Shyh-Chang et al.,
2011). Curiously, mouse ESCs rely uniquely upon mitochondrial
oxidation of threonine (Thr) into glycine (Gly) via threonine dehy-
drogenase to generate one carbon and folate intermediates to
fuel rapid nucleotide synthesis (Wang et al., 2009). This seminal
early work led to findings that the 5-methyl-THF generated by
mitochondrial Thr oxidation also fuels the synthesis of S-adeno-
syl methionine (SAM) to regulate histone H3K4 methylation and
the pluripotency of ESCs (Shyh-Chang et al., 2013a). Surpris-
ingly, Lin28a overexpression in ESCs leads to a dramatic accu-
mulation of many metabolites in the Thr-Gly-SAM pathway,
whereas overexpression of let-7 reduces the abundance of
these metabolites, suggesting that the Thr-Gly-SAM pathway
is at least indirectly regulated by the Lin28/let-7 switch to main-
tain ESC self-renewal. These findings might also have relevance
to cancer, given that lung cancer stem cells have been found to
express and depend upon high levels of both Lin28b and glycine
decarboxylase in the Thr-Gly pathway to initiate tumorigenesis
(Zhang et al., 2012). In fact, several enzymes in Gly metabolism
have recently been implicated in human tumorigenesis (Locasale
et al., 2011; Possemato et al., 2011; Jain et al., 2012). Thus, Lin28
could potentially regulate glucose and amino acid metabolism in
a variety of stem and progenitor cells, including those that are
both normal and malignant (Shyh-Chang et al., 2013b).
Lin28 in Early Embryogenesis, Pluripotent Stem Cells,
and Reprogramming
The earliest phases of embryogenesis feature high levels of
Lin28a because of protein inheritance through the maternal
oocyte. From the mouse zygote to the preimplantation blasto-
cyst, Lin28a is exclusively localized in the nucleolus where it is
thought to regulate nucleolar maturation (Vogt et al., 2012).
Morpholino knockdown of Lin28a in the zygote produces
defects in nucleolar morphology and developmental arrest at
the 2-cell and 4-cell stages, suggesting that Lin28a is required
for proper nucleolar genesis and function and early embryogen-
esis. Curiously, Lin28a is localized in the nucleolus of mouse
ESCs as well but is not localized in primate ESCs (Vogt et al.,
2012). Given that Lin28a is an RNA-binding protein, these obser-
vations suggest that maternal Lin28a might also be involved in
ribosomal RNA processing in the nucleolus for the regulation of
zygotic genome activation during the maternal to zygotic transi-
tion, although this remains speculative.After zygotic genome activation, mammalian blastocysts
show high levels of Lin28a and Lin28b transcription in the plurip-
otent cells of the inner cell mass (ICM) and epiblast and their
in vitro correlates—the indefinitely self-renewing ESCs. Studies
suggest that Lin28a and Lin28b act as repressors of let-7
miRNAs to prevent premature differentiation in the pluripotent
ICM and epiblast (Suh et al., 2010; Melton et al., 2010). When
the pluripotent ICM is cultured in vitro for ESC derivation,
Lin28a is further upregulated, in parallel with the acquisition of
indefinite self-renewal capacity in vitro (Tang et al., 2010).
Furthermore, overexpression of Lin28a with a cocktail of the
core pluripotency-associated transcription factors Oct4, Sox2,
and Nanog helps promote the reprogramming of human somatic
fibroblasts into indefinitely self-renewing iPSCs (Yu et al., 2007a;
Hanna et al., 2009). These data suggest that Lin28a is critical to
pluripotent stem cell self-renewal.
But is Lin28 also required for pluripotency? Lin28 knockout
mouse models suggest that the answer is no. Lin28a knockout
mice progress through the blastocyst stage without obvious
developmental defects in utero, although they weigh 20% less
at birth (Zhu et al., 2010). Lin28b knockout mice are viable and
fertile. Thus, Lin28a and Lin28b do not appear to be essential
per se for pluripotency in vivo.
Do pluripotent stem cells then require Lin28a and Lin28b for
indefinite self-renewal? The answer depends on the context,
given that overexpression of mature let-7 does not inhibit mouse
ESC self-renewal unless DGCR8 is knocked out and miRNA
biogenesis is prevented (Melton et al., 2010). Another class of
miRNAs called the miR-290 family can respond to and compen-
sate for the effects of let-7 overexpression. Although the breadth
of genes targeted by the miR-290 family and their connections
with Lin28a and Lin28b (if any) remain unclear, it is thought that
let-7 promotes ESC differentiation only in the absence of
DGCR8 by directly repressing Sall4, Nmyc, and Lin28a.
Conversely, Lin28a or Lin28b knockout in the presence of
DGCR8 should not lead to defects in self-renewal via let-7 upre-
gulation alone, even if we ignore the compensatory redundancy
observed between Lin28a and Lin28b (Wilbert et al., 2012). How-
ever, RNA interference against Lin28 does lead to proliferative
defects in both mouse and human ESCs (Xu et al., 2009; Peng
et al., 2011), suggesting that Lin28a and Lin28b might synergis-
tically promote ESC self-renewal through a combination of let-7
repression and let-7-independent mechanisms, such as direct
binding of mRNAs involved in metabolism and growth. Thus, it
will also be interesting to see if Lin28a and Lin28b double
knockout leads to defects in ESC self-renewal. On the other
hand, let-7 knockdown in fibroblasts promotes iPSC reprogram-
ming (Melton et al., 2010), suggesting that Lin28a might promote
self-renewal via repression of let-7 during iPSC reprogramming
without compensatory effects from ESC-specific miR-290.
Indeed, studies have shown that Lin28a can accelerate the early
stochastic phase of iPSC reprogramming by accelerating the cell
cycle and that Lin28a is one of the earliest markers of the deter-
ministic phase of iPSC reprogramming after endogenous Sox2
expression is induced (Hanna et al., 2009; Buganim et al.,
2012; Golipour et al., 2012). However, it remains to be verified
whether let-7 is the relevant target of Lin28a during reprogram-
ming and what downstream targets of let-7 drive iPSC reprog-
ramming. It is also unknown whether Lin28/let-7 is implicatedCell Stem Cell 12, April 4, 2013 ª2013 Elsevier Inc. 399
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Reviewin the much more rapid and deterministic process of reprogram-
ming by somatic cell nuclear transfer.
Lin28 in Normal and Transformed Tissue Progenitors
Contrary to popular belief, the expression of Lin28a and Lin28b
and their influence on development is far from unique to pluripo-
tent cells in the blastocyst ICM, but, rather, extends to a variety
of tissues. For instance, the trophoblast (Vogt et al. 2012) and
the resultant placental tissues (Sangiao-Alvarellos et al. 2013)
show high levels of Lin28a and Lin28b. Moreover, the LIN28B
locus shows imprinting and paternal monoallelic expression
in the human placenta (Barbaux et al., 2012). However, the
placental function of Lin28 remains unclear in vivo.
Germline stem cells also retain high levels of Lin28 expression
during mammalian development. Lin28a promotes primordial
germ cell (PGC) specification via let-7 regulation of the master
regulator Blimp1 (West et al., 2009) and remains high specifically
in the spermatogonial stem cells of adult male testes (Zheng
et al., 2009). Both Lin28a knockout and let-7 overexpression
led to a reduction in PGCs during embryogenesis and a reduc-
tion in proliferating spermatogonia and germ cells before
adulthood (Shinoda et al., 2013). Interestingly, aberrant overex-
pression of Lin28a and Lin28b is associated with the malignancy
of human germ cell tumors, such as choriocarcinomas, embry-
onal carcinomas, seminomas, yolk sac tumors, and mixed
germ cell tumors (West et al., 2009; Cao et al., 2011a; Cao
et al., 2011b; Gillis et al., 2011; Xue et al., 2011). Overexpression
of Lin28a produces higher-grade teratomas, whereas Lin28a
knockdown leads to smaller teratomas, suggesting that Lin28a
acts as an oncogene in germ cell tumors by enhancing the
self-renewal of PGCs and spermatogonial stem cells (West
et al., 2009).
Although Lin28a and Lin28b decline rapidly upon implantation
(Tang et al., 2010), high levels of Lin28 persist in the neural tube
and neural crest (Yang and Moss, 2003; Balzer et al., 2010).
miR-125 is thought to promote neural differentiation, in part by
downregulating Lin28a in neural stem cells (Wulczyn et al.,
2007; Rybak et al., 2008). Lin28a and Lin28b overexpression,
in turn, regulates the balance of neurogenesis and gliogenesis
in vitro (Balzer et al., 2010) and leads to an abundance of primi-
tive neural tissue in teratomas formed by ESCs (West et al.,
2009). By increasing Nmyc, conditional overexpression of
Lin28b in neural crest progenitors in mice could inhibit neuronal
differentiation and lead to neuroblastoma (Molenaar et al., 2012).
Interestingly, a genome-wide association study also found a
Lin28b variant with higher expression is associated with higher
neuroblastoma risk in humans (Diskin et al., 2012). This suggests
that dysregulation of Lin28b in neural crest progenitors, which
normally show only limited self-renewal, can provoke transfor-
mation into neuroblastoma. Lin28a is also highly expressed in
aggressive primitive neuroectodermal brain tumors and medul-
loblastoma, although its oncogenic role in these tumors remains
less clear (Picard et al., 2012; Rodini et al., 2012).
Within the developing mesodermal tissues, fetal hemato-
poietic stem and progenitor cells (HSPCs) express high levels
of Lin28b, whereas adult HSPCs do not (Yuan et al., 2012). Over-
expression of Lin28a alone in adult Lin bone marrow cells can
reprogram some of them into fetal-like lymphoid progenitors
(Yuan et al., 2012), which may be relevant to the oncogenic400 Cell Stem Cell 12, April 4, 2013 ª2013 Elsevier Inc.role of Lin28 in T cell lymphoma and leukemia (Beachy et al.,
2012; Rao et al., 2012). However, in acute myeloid leukemia
(AML), Lin28a appears to act as an oncogene in MLL-driven
AML on one end of the spectrum and as a tumor suppressor in
miR-125-driven AML on the other (Jiang et al., 2012; Chaudhuri
et al., 2012). It is especially interesting thatmiR-125 overexpres-
sion alone can promote the self-renewal of long-term adult HSCs
to cause a variety of myeloid and lymphoid malignancies in both
mice and humans (Bousquet et al., 2008, 2010; Guo et al., 2010;
O’Connell et al., 2010; Ooi et al., 2010; Chaudhuri et al., 2012),
even though themiR-125 homolog lin-4 promotes differentiation
in nematode stem cells. The unresolved questions surrounding
miR-125 and Lin28’s roles in hematopoiesis indicate that our un-
derstanding of how the miR-125-Lin28-let-7 pathway regulates
hematopoiesis remains incomplete.
In another mesoderm-derived tissue, muscle stem cells or
satellite cells have not been observed to express Lin28a and
Lin28b , but proliferative myoblasts do upregulate Lin28a during
muscle regeneration (Polesskaya et al., 2007). Loss of Lin28a by
small interfering RNA knockdown inhibits myogenesis, whereas
Lin28a overexpression promotes myogenesis, at least in vitro.
This process depends on the direct stimulation of Igf2 translation
(Polesskaya et al., 2007) and probably other Lin28a targets in
cellular growth and metabolism (Zhu et al., 2011). Although
muscle development does not seem overtly affected in Lin28a
transgenic or knockout mice (Zhu et al., 2010; Zhu et al.,
2011), it remains to be tested whether Lin28a and Lin28b are
functionally important in muscle regeneration upon injury or in
rhabdomyosarcoma growth in vivo.
Despite tremendous progress in our knowledge of Lin28 func-
tion in tissues of germline, ectodermal, and mesodermal origin,
little is known about Lin28 function in endodermal tissues.
Lin28 expression has been detected in the fetal liver, kidney, in-
testines, and lung by immunohistochemistry (Yang and Moss,
2003). A variety of cancers involving these tissues express
Lin28b, including hepatocellular carcinoma, Wilm’s tumor, colo-
rectal cancer and lung cancer—suggesting that Lin28a and
Lin28bmight play a role in both the normal development andma-
lignancy of endodermal tissues (Guo et al., 2006; Viswanathan
et al., 2009; King et al., 2011; Zhang et al., 2012). Given the
limitations of immunohistochemistry in small cellular compart-
ments and the expectation that Lin28 may only be active in
stem or progenitor cells, careful analyses using tissue specific
Cre- or Cre-ER-driven mouse models are needed to rigorously
address the role of Lin28a and Lin28b in tissue development
by lineage tracing.
Lin28 in Re-engineering of Mammalian Physiology
It has been proposed that Lin28 is an oncofetal gene with little
physiological relevance in normal adult tissues (Boyerinas
et al., 2008; Peter 2009). Given that Lin28a and Lin28b are pri-
marily expressed during embryogenesis and largely silent in
most adult tissues, one could argue that these proteins bear little
relevance to normal adult human physiology except when reac-
tivated in the setting of malignancy. Evolutionarily, this could
be because of Lin28’s potency in promoting stem cell self-
renewal, and, hence, tumorigenesis, if dysregulated. Another
gene endowed with similar properties is the catalytic component
of telomerase, Tert, which is likewise predominantly expressed
Figure 3. Potential of Lin28 in Re-
engineering Adult Mammalian Physiology
Lin28a, in conjunction with the pluripotency
factors Oct4, Sox2, and Nanog, can reprogram
somatic cells into iPSCs. Alone, Lin28a and Lin28b
can reprogram adult HSPCs into a fetal-like state
and enhance insulin sensitivity in the skeletal
muscles to improve glucose homeostasis, resist
obesity, and prevent diabetes. Emergent clues
suggest that optimal doses of Lin28a and Lin28b
might have the potential to re-engineer adult
mammalian tissue repair capacities and extend
longevity, although Lin28a and Lin28b could also
cooperate with oncogenes to initiate tumorigen-
esis. Future work might elucidate these mysteries.
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stem cells, and in cancers (Kolquist et al., 1998; Schaetzlein
et al., 2004). Despite its initial apparent irrelevance to adult phys-
iology—telomerase knockout mice are healthy and viable for the
first few generations (Blasco et al., 1997; Yuan et al., 1999)—Tert
has gained preeminence as an agent for re-engineeringmamma-
lian adult cells by immortalizing cells and extending lifespan
in vivo while being a potential target in cancer therapy (Sahin
and Depinho, 2010). Could Lin28 show similar potential in re-
engineering adult human cells (Figure 3)?
The answer appears to be in the affirmative. Altogether, the
demonstrations that Lin28a overexpression with Oct4, Sox2,
and Nanog can help reprogram adult human fibroblasts into
ESC-like iPSCs (Yu et al., 2007a), that Lin28a overexpression
can reprogram adult HSPCs into a fetal-like HSPCs (Yuan
et al., 2012), and that Lin28b overexpression can expand neural
crest progenitors (Molenaar et al., 2012) suggest that Lin28
overexpression might be useful for promoting stem cell
or progenitor self-renewal in vitro. This is conceptually distinct
from Tert-based immortalization of any somatic cell, given
that Lin28 appears to counteract cellular differentiation,
whereas Tert counteracts replicative senescence. If Lin28 can
enhance self-renewal, what effects would it exert on adult
tissue repair in vivo? Although Lin28’s effects on mammalian
tissue repair remain unexplored, a study has shown that zebra-
fish Lin28 can promote retinal regeneration by repressing let-7
(Ramachandran et al., 2010). This finding hints at the possibility
that Lin28 might also extend the limits of mammalian tissue
repair upon injury—a hypothesis that awaits further testing
(Figure 3).
In the same vein, the Lin28/let-7 pathway could impact
longevity, although it remains unclear whether Lin28 overexpres-
sion would promote or delay aging. Given that Lin28 upregulates
and let-7 downregulates insulin-PI3K signaling in mammals
(Zhu et al., 2011) and that insulin-PI3K signaling also regulates
mammalian aging in an evolutionarily conserved fashion, oneCell Stem Cemight expect Lin28 to promote and let-7
to delay aging in mammals. This would
concur with several studies showing
that several long-lived mouse strains like
the Ames, Snell, GHRKO, and Igfr1+/
mice are all dwarfed (Bartke 2012), similar
to mice overexpressing let-7 (Zhu et al.,
2011; Frost and Olson, 2011). However,improved insulin sensitivity, a prominent phenotype of mice
overexpressing Lin28a or Lin28b, is also associated with
longevity (Barbieri et al., 2003) and is indicative of how longevity
can be regulated by a multifaceted network of factors. Adding to
this complexity, deficiency in tissue repair can accelerate aging
as shown in telomerase-deficient and p53-overexpressing mice
(Rudolph et al., 1999; Tyner et al., 2002), but hyperactive tissue
regeneration can also lead to stem cell exhaustion and shorter
lifespans, as shown in models of Pten/ myelodysplasias and
muscular dystrophy (Yilmaz et al., 2006; Sacco et al., 2010). It
could well be that only the precise dosage of Lin28/let-7 that
strikes an optimal equilibrium between insulin signaling and
tissue repair would enhance mammalian longevity.
As is the case with telomerase, a wide variety of cancers reac-
tivate Lin28 to re-engineer their cellular states (Viswanathanet al.,
2009). Although the oncogenic role of Lin28a and Lin28b has only
been demonstrated in vivo for a small subset of cancers,
including neuroblastoma, T cell acute lymphoblastic leukemia,
and peripheral T cell lymphoma (Molenaar et al., 2012; Beachy
et al., 2012; Rao et al., 2012), the cancer stem cell model seems
to apply in all these cases, Lin28 being the stem cell factor pro-
moting self-renewal. The cancer stem cell model posits that can-
cers are maintained by a small population of tumor-sustaining
cancer stem cells with self-renewal capacity (Rosen and Jordan,
2009). Although the cancer stem cell model has engendered
debate and does not apply universally to all cancers, as shown
most convincingly in advanced melanoma (Quintana et al.,
2008, 2010; Boiko et al., 2010), leukemias, germ cell tumors,
and many other solid cancers appear to follow the cancer stem
cell model (Ishizawa et al., 2010). Boiko et al., 2010, have pro-
posed that, in the earliest stages of melanoma, rare cancer
stem cells differentiate into nonmalignant progeny to form the
bulk of the tumor, whereas, in the advanced stages, cancer
stem cell clones dominate and constitute the bulk of the tumor
(Boiko et al., 2010). These findings suggest that targeting cancer
cell heterogeneity may be a relevant approach for eradicatingll 12, April 4, 2013 ª2013 Elsevier Inc. 401
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moting stem cell and progenitor self-renewal is also its essential
mechanism for promoting tumorigenesis, then Lin28 would
represent a promising universal factor for therapeutic targeting
in a wide variety of cancer stem cells. This exciting prospect
warrants attempts to drug the Lin28 pathway.
Conclusion
Seminal observations made nearly three decades ago by
Ambros and Horvitz on the role of Lin28 in C. elegans hetero-
chronic reiterations have spawned great leaps in our under-
standing of how posttranscriptional RNA processing can
regulate stem cells. Recent advances are painting a detailed
picture of how Lin28 regulates let-7 miRNA biogenesis and
mRNA translation to coordinate both cellular metabolism and
proliferative growth pathways for the purpose of stem cell self-
renewal. Although much effort has been expended to elucidate
the let-7 miRNA regulatory mechanism, it is imperative that we
also understand how Lin28a and Lin28b regulate mRNA
processing and trafficking between the nucleus, ribosomes,
P-bodies, and stress granules—a mystery that remains unre-
solved. What conditions or pathways regulate the mechanism
of Lin28a or Lin28b within the nucleolus, the cytoplasm, and
P-bodies? How do these mechanisms affect Lin28a and
Lin28b function in tissue stem cells and progenitors, especially
those derived from the endoderm, given its preponderance in
colon, kidney, liver, and lung cancers? Can we harness Lin28
to re-engineer and improve mammalian tissue repair and
longevity or target it for cancer therapy? We hope to answer
these questions, and more, in the coming decade.
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